80.05
-2.52
(-3.05%)
At close: January 10 at 4:00:02 PM EST
80.56
+0.51
+(0.64%)
After hours: January 10 at 7:51:49 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| COLEMAN MARK H Director | Conversion of Exercise of derivative security | Jan 3, 2025 | 460,993 |
| JACOBSON MARK L Chief Operating Officer | Conversion of Exercise of derivative security | Aug 9, 2024 | 5,783 |
| JEFFS ROGER A Director | Conversion of Exercise of derivative security | Mar 15, 2024 | 167,668 |
| SAAD MARK E Director | Conversion of Exercise of derivative security | Sep 11, 2024 | 10,302 |
Related Tickers
TGTX TG Therapeutics, Inc.
28.88
+0.38%
MDGL Madrigal Pharmaceuticals, Inc.
338.91
+1.66%
AVXL Anavex Life Sciences Corp.
11.23
-1.75%
IOVA Iovance Biotherapeutics, Inc.
6.40
-10.74%
VRNA Verona Pharma plc
45.20
-2.16%
VKTX Viking Therapeutics, Inc.
39.31
-3.18%
ALT Altimmune, Inc.
6.87
-7.79%
ATRA Atara Biotherapeutics, Inc.
15.55
-5.93%
AUPH Aurinia Pharmaceuticals Inc.
8.07
-3.24%
SRPT Sarepta Therapeutics, Inc.
124.79
-1.17%